Helvoet Pharma to build production facility in India
Helvoet Pharma is to build a new modern production facility in India. This new
plant will begin operation in 2012 and will supply the local pharmaceutical
industry and globally operating pharmaceutical customers with rubber
components for primary packaging for parenteral pharmaceutical and
With this facility, Helvoet Pharma is further strengthening its market position in
India and establishing its first operational platform in Asia to further capitalise
on its worldwide leadership in pharmaceutical rubber formulations.
Helvoet Pharma's decision to build its own manufacturing plant in India has been
made to leverage the country's position as the centre of excellence for generic and
branded pharmaceutical products. India has the highest number of US FDA
approved plants outside the USA and is expected to become a significant healthcare
This brand-new plant fully equipped with state-of-the-art facilities built to Helvoet
Pharma’s high standards will be operational in 2012. Over the next two years,
Helvoet Pharma will spend some 14 million Euros. Construction work for the
greenfield production facility will start in the third quarter of this year. The new plant
will be located near Pune (Maharashtra state) in a newly developed industrial zone
with a secure energy supply, good transport connections and access to trained
personnel. If required, the new facility can be expanded modularly in the future.
About Helvoet Pharma – “Passion for Excellence” (www.helvoetpharma.com)
Helvoet Pharma, a leading global supplier of primary and secondary pharmaceutical
packaging components, was founded in 1970. The company is headquartered in Europe and
has additional manufacturing facilities located in Europe, the USA and Asia, supplying over 10
billion parts to the pharmaceutical industry every year. Helvoet Pharma currently employs a
total of 1,250 people worldwide and generated sales revenues of 170 million euros in 2008.
Helvoet Pharma is part of the Swiss Daetwyler Group, which has some 4,700 employees and
generates more than 800 million euros in revenue.
For over four decades, Helvoet Pharma has continued to build upon its reputation for
reliability, high quality products and customer support.
Enquiries: Mr Dirk Borghs – Special Projects Leader Helvoet Pharma
Phone : +32/1159 0985